RRML - Involvement of inflammatory markers in pathogenesis of venous thromboembolism

ISSN online: 2284-5623

ISSN-L: 1841-6624

Impact factor (2019): 0.945

Rejection rate (2016): 55%

Română English

Clarivate analytics (ISI) Impact factor

Advanced search

Top 10 downloaded articles
- July 2020 -
Multiplex ligation-dependent p... 3
Romanian Review of Laboratory ... 2
Undetectable hemoglobin in a p... 2
Implications of visfatin genet... 2
Antimicrobial activity of diff... 2
The predictive role of platele... 2
Genetic variability of ANG2 -3... 2
Validation of GOD / PAP method... 1
A model for calculating measur... 1
Bioanalytical method validatio... 1

Log in

Concept, Design & Programming
Dr. Adrian Man

Nr. 25(3)/2017 DOI:10.1515/rrlm-2017-0019


Involvement of inflammatory markers in pathogenesis of venous thromboembolism

Alexandra Florina Cocoi, Dana Pop, Mihai Cocoi, Adela Mihaela Serban, Luminita Animarie Vida-Simiti

Correspondence should be addressed to: Alexandra Florina Cocoi


Inflammation of the venous wall is involved in thrombogenesis, thrombus resolution, wall remodeling and the post-thrombotic syndrome. Different mechanisms are involved in both arterial and venous thrombosis and patients with atherothrombosis hold a higher risk of venous thrombosis. Although inflammation may represent the connection between arterial and venous thrombosis, it is not yet sure if it is the cause or consequence of venous thrombosis. Consequently, the relationships between inflammation markers as indicators of the inflammatory process and clinical venous thromboembolism need to be investigated. For example, inflammation mediators such as the pro-inflammatory cytokines interleukin 8 (IL-8), IL-6, monocyte chemotactic protein 1 (MCP-1), C Reactive Protein (CRP), vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), matrix metalloproteinases and tumor necrosis factor alpha (TNF alpha) are all involved in thrombogenesis. Studies of venous thromboembolism on animal models proved that there are specific phases of the inflammatory process in venous thromboembolism and thrombus resolution. Knowing the molecular and immunologic mechanisms, identifying and understanding the inflammation markers which are relevant for venous thrombosis, can help to target specific pathways and to develop future therapies of this disease.

Keywords: thrombembolism, markers, inflammation, thrombus, venous thrombosis

Received: 21.2.2017
Accepted: 28.5.2017
Published: 10.7.2017

  PDF Download full text PDF
(327 KB)
How to cite
Cocoi AF, Pop D, Cocoi M, Serban AM, Vida-Simiti LA. Involvement of inflammatory markers in pathogenesis of venous thromboembolism. Rev Romana Med Lab. 2017;25(3):227-36. DOI:10.1515/rrlm-2017-0019